FR3112478B1 - Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation - Google Patents

Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation Download PDF

Info

Publication number
FR3112478B1
FR3112478B1 FR2007406A FR2007406A FR3112478B1 FR 3112478 B1 FR3112478 B1 FR 3112478B1 FR 2007406 A FR2007406 A FR 2007406A FR 2007406 A FR2007406 A FR 2007406A FR 3112478 B1 FR3112478 B1 FR 3112478B1
Authority
FR
France
Prior art keywords
peptide
new compositions
compositions combining
derivatives
hemp derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2007406A
Other languages
English (en)
Other versions
FR3112478A1 (fr
Inventor
Michel Hocquaux
Jean-Christophe Aubagnac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
France Cosmephyl Lab
Original Assignee
France Cosmephyl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by France Cosmephyl Lab filed Critical France Cosmephyl Lab
Priority to FR2007406A priority Critical patent/FR3112478B1/fr
Priority to CN202180060708.4A priority patent/CN116615171A/zh
Priority to EP21742138.7A priority patent/EP4181868A1/fr
Priority to CA3185341A priority patent/CA3185341A1/fr
Priority to US18/005,123 priority patent/US20230255864A1/en
Priority to PCT/EP2021/069472 priority patent/WO2022013227A1/fr
Publication of FR3112478A1 publication Critical patent/FR3112478A1/fr
Application granted granted Critical
Publication of FR3112478B1 publication Critical patent/FR3112478B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation La présente invention concerne une association comprenant ou constituée d’un mélange de cannabidiol et de palmitoyl tripeptide-8 et son utilisation pour traiter ou apaiser les peaux sensibles et/ou réactives ou comme après solaire pour apaiser les érythèmes solaires. (Pas de figure)
FR2007406A 2020-07-15 2020-07-15 Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation Active FR3112478B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2007406A FR3112478B1 (fr) 2020-07-15 2020-07-15 Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation
CN202180060708.4A CN116615171A (zh) 2020-07-15 2021-07-13 组合有大麻衍生物和至少一种肽的新型组合产品及其用途
EP21742138.7A EP4181868A1 (fr) 2020-07-15 2021-07-13 Nouvelles compositions associant des derives de chanvre et au moins un peptide et leur utilisation
CA3185341A CA3185341A1 (fr) 2020-07-15 2021-07-13 Nouvelles compositions associant des derives de chanvre et au moins un peptide et leur utilisation
US18/005,123 US20230255864A1 (en) 2020-07-15 2021-07-13 Novel compositions combining hemp derivatives and at least one peptide and use thereof
PCT/EP2021/069472 WO2022013227A1 (fr) 2020-07-15 2021-07-13 Nouvelles compositions associant des derives de chanvre et au moins un peptide et leur utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2007406 2020-07-15
FR2007406A FR3112478B1 (fr) 2020-07-15 2020-07-15 Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation

Publications (2)

Publication Number Publication Date
FR3112478A1 FR3112478A1 (fr) 2022-01-21
FR3112478B1 true FR3112478B1 (fr) 2022-12-02

Family

ID=73401633

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2007406A Active FR3112478B1 (fr) 2020-07-15 2020-07-15 Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation

Country Status (6)

Country Link
US (1) US20230255864A1 (fr)
EP (1) EP4181868A1 (fr)
CN (1) CN116615171A (fr)
CA (1) CA3185341A1 (fr)
FR (1) FR3112478B1 (fr)
WO (1) WO2022013227A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835528B1 (fr) 2002-02-01 2004-03-12 Inst Europ Biolog Cellulaire Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
FR2870243B1 (fr) * 2004-05-11 2010-11-19 Centre Nat Rech Scient Conjugues tripeptidiques agonistes de la msh
WO2020024056A1 (fr) * 2018-08-01 2020-02-06 Lazar Eve Compositions comprenant des cannabinoïdes et matériau absorbable et utilisations associées
CN109998939A (zh) * 2019-04-26 2019-07-12 广州恒雅生物化工有限公司 抗皱紧肤组合物、抗皱紧肤精华液及其制备方法
US11446277B2 (en) * 2019-08-01 2022-09-20 Felice Soule Penetrating pain relief cream

Also Published As

Publication number Publication date
CA3185341A1 (fr) 2022-01-20
CN116615171A (zh) 2023-08-18
US20230255864A1 (en) 2023-08-17
EP4181868A1 (fr) 2023-05-24
FR3112478A1 (fr) 2022-01-21
WO2022013227A1 (fr) 2022-01-20

Similar Documents

Publication Publication Date Title
MA26961A1 (fr) Agonistes selectifs des recepteurs ep4 pour le traitement de l'osteoporose
MA44851A (fr) Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations
BR0209709A (pt) Composições hipotensivas de lipìdio e timolol e métodos de uso das mesmas
MA27427A1 (fr) Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie
MA27728A1 (fr) Antagonistes des recepteurs de cgrp
MX2023000257A (es) Composiciones a base de aloe que comprenden polisacaridos y polifenoles para la regulacion de la homeostasis de la inmunidad.
MA30410B1 (fr) Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique.
FR3091873B1 (fr) Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
IN2014KN01260A (en) Composition based on red henna powder and oil(s) and hair dyeing process using this composition
FR2968209B1 (fr) Compositions cosmetiques contenant une silicone non aminee, un ester gras liquide et une silicone aminee, procedes et utilisations
TR200200066T2 (tr) Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri
FR3117020B1 (fr) Composition solide anhydre comprenant des tensioactifs carboxylates et amphotères ou zwittérioniques et des silicones
FR3112478B1 (fr) Nouvelles compositions associant des dérivés de chanvre et au moins un peptide et leur utilisation
FR3117021B1 (fr) Composition solide anhydre comprenant un tensioactif anionique et un mélange d’acide citrique et de bicarbonate
BR112022020315A2 (pt) Novos compostos anti-helmínticos
FR2970971B1 (fr) Utilisation d'au moins un co-produit de l'industrie du raffinage des huiles vegetales pour obtenir un insaponifiable total purifie d'huile vegetale.
MX2023005273A (es) Composiciones farmaceuticas de un inhibidor de cinasa.
FR3072030B1 (fr) Compositions deodorantes cosmetiques et dermatologiques presentant une tenue de fragrance amelioree et de longue duree
EA200401210A1 (ru) Андрогенная фармацевтическая композиция и способ для лечения депрессии
FR3104025B1 (fr) Nouvelles compositions cosmétiques
FR3076713B1 (fr) Utilisation d'hemoglobine d'annelides comme bactericide, notamment pour prevenir et/ou traiter une maladie parodontale
FR3097439B1 (fr) Composition comprenant au moins un alcoxysilane, au moins une silicone non aminée et de l’eau, le ratio massique d’alcoxysilane/silicone non aminée variant de 95 :5 à 5 :95
CY1112612T1 (el) Συνθεση φινιρισματος για κατεργασια νηματων
FR3090376B1 (fr) Extrait aqueux de fruits de Rose comme agent neuro-protecteur cutané
AU2001290962A1 (en) Methods of preparing immune globulin and uses thereof

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220121

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4